The global gabapentin drug market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). Gabapentin is an anti-convulsants, a type of medication that controls seizures in people with epilepsy disorder. The increase in the prevalence of epilepsy disease has created a demand for the development of new drugs for its treatment which in turn drives the global gabapentin drugs market growth. In addition, leading pharmaceutical companies are focusing on the development of gbapentin drugs for epilepsy disorder treatment. In addition, the market growth is driven by the strong focus of the pharmaceutical companies and research organizations on the R&D of drugs for gabapentin.
(Get 15% Discount on Buying this Report)
A full report of Global Gabapentin Drug Market is available at: https://orionmarketreports.com/gabapentin-drug-market/93074/
However, the rising costs of treatments along with stringentregulatory policies related to this drug usage are expected to hamper the market growth. The emerging economies that are focusing on healthcare development are expected to offer lucrative opportunities to the growth of the gebapentin drug market.
GlaxoSmithKline plc, Sanofi SA, Pfizer Inc.,and Cipla Inc. are the key market players that are contributing significantly to the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches. For instance, in June 2019, GlaxoSmithKline plc announced the launch of a dispersed Lamictal tablet (lamotrigine dispersible tablet) for the treatment of epilepsy in the Chinese market.
In the same month, Lupine Ltd. had launched its standard Clobazam tablets in the US to treat a patient suffering from epilepsy since childhood and the company introduced Clobazam tablets in doses of 10 mg and 20 mg, after receiving approval from the US FDA.
Market Coverage
- The market number available for – 2021-2028
- Base year- 2021
- Forecast period- 2022-2028
- Segment Covered-
- By Type
- By Application
Key questions addressed by the report
- What is the market growth rate?
- Which segment and region dominate the market in the base year?
- Which segment and region will project the fastest growth in the market?
- How has COVID-19 impacted the market?
- Deviation from the pre-COVID-19 forecast
- Most affected region and segment
- Who is the leader in the market?
- How players are addressing challenges to sustain growth?
- Where is the investment opportunity?
Global Gabapentin Drug Market Report by Segment
By Type
- Capsule
- Tablet
- Oral Solution
By Application
- Epilepsy
- Neuropathic Pain
- Restless Legs Syndrome
About Us:
Orion Market Reports (OMR) endeavors to provide an exclusive blend of qualitative and quantitative market research reports to clients across the globe. Our organization helps both multinational and domestic enterprises to bolster their business by providing in-depth market insights and the most reliable future market trends. Our reports address all the major aspects of the markets providing insights and market outlook to global clients.
Media Contact:
Company Name: Orion Market Reports
Contact Person: Mr. Anurag Tiwari
Email: info@orionmarketreports.com
Contact no: +91 780-304-0404
